Since 2013, MedTech Innovator and its sister programs: MedTech Innovator Asia Pacific and BioTools Innovator, have supported the growth of best-in-class startups through a proven model of visibility, partnership, and mentorship. With over 717 alumni companies that have secured $10.3 billion in follow-on equity funding and with more than 93% are still in business or have been successfully acquired our-track record speaks for itself.
Alumni Companies
Follow-On Equity Funding
Still in Business or Acquired
Products On the Market
Acquisitions
Investment $ to Alumni
What makes the Innovator programs unique?
We accelerate the top startups in medical technology, life science tools, diagnostics, and digital health.
We accelerate the top startups in medical technology, life science tools, diagnostics, and digital health.
Our annual cohort is selected through a highly competitive process:
Once selected, companies join a five-month virtual accelerator (June–November) packed with expert mentorship, investor exposure, and hands-on commercialization support. Finalists compete live at major industry events for non-dilutive funding, awards, and unparalleled visibility.
Joining MTI isn’t a one-and-done experience. Alumni continue to benefit from:
We support innovators globally through three distinct programs:
PROGRAM | WHO’S ELIGIBLE | KEY BENEFITS |
---|---|---|
MTI US | Early- to mid-stage med device, diagnostics, or digital health companies with US market interest |
|
MTI APAC | Early- to mid-stage med device, diagnostics, or digital health companies based in or entering Asia-Pacific |
|
BTI | Life science tools or diagnostics companies |
|
Applications open on October 6, 2025. Join our waitlist and be the first to know:
Are you a current partner or sponsor helping us amplify the call for applicants?
Access our Media Kit with logos, social assets, sample copy, and more: